Dr. Huile Gao is currently a Full Professor of West China School of Pharmacy, Sichuan University, Chengdu, China. He received his Bachelor's degree and Ph.D. in Pharmaceutics from School of Pharmacy, Fudan University in 2008 and 2013, respectively. Dr. Gao's research interests focus on the design, synthesis, characterization and evaluation of stimuli responsive nanomaterials for drug delivery to improve treatment and diagnosis of human diseases especially tumor and brain diseases. He has published over 100 peer-reviewed articles with an H-index of 46. His research is supported by National Natural Science Foundation of China and other grants. He was awarded as Young Chang Jiang Scholar by Ministry of Education (2018), Young Elite Scientists Sponsorship Program by CAST, and Young Pharmaceutics Scientist by Chinese Pharmaceutical Association. He served as editor of the two English books. He is now serving as Editorial Board Member of International Journal of Pharmaceutics, Pharmaceutics, CNS & Neurological Disorders-Drug Targets, Current Drug Metabolism and Journal of Microencapsulation.
Dr. Zhiqing Pang is an associate researcher of School of Pharmacy, Fudan University. He obtained his Ph.D. in Pharmaceutics from Fudan University in 2008. His research mainly focuses on targeting drug delivery systems. He published >100 peer-review scientific papers, with citation by >4000 times (H-index ∼40); coedited 4 books in English and 3 books in Chinese. His scientific achievements have been honored by some scientific awards in China, including National Award for Science and Technology (2018); Distinguished Young Scholar of Chinese Piharmaceutical Association–Sanofi, Natural Science Award of Ministry of Education (2010).
Dr. Wei He is an associate professor at the College of Pharmaceutical Science, China Pharmaceutical University (since Jul. 2012). He obtained his Ph.D. degree from Fudan University, worked as a project leader in CSPC Pharmaceutical Co., Ltd. from 2007 to 2009, as a researcher at Alberta University (Canada) and as a visiting scholar at Harvard University from Nov. 2018 to Oct. 2019. His current research interest mainly includes drug delivery, pharmaceutical science and treatment of inflammatory disease such as cardiovascular disease.
Footnotes
Peer review under responsibility of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.